Balanced & Conservative Portfolio
Add 2.5% Ebos Group Ltd (EBO) & Add 2.5% Betashare Global Healthcare ETF (DRUG)
Date: 18/1/2024
*** GENERAL AVICE ONLY***
Catalyst
Allocating 2.5% into each healthcare stock & ETF aligns with our market outlook, anticipating robust demand in this sector. Amid economic uncertainties, healthcare remains resilient, benefiting from consistent needs and innovation. This strategic move offers stability and growth potential in a fluctuating market. EBOS has strong fundamentals where it has outperformed expectations over the last couple of years. It is currently undervalued due to termination of it’s contract with Chemist Warehouse in Jun 2024.
DRUG ETF constituents Eli Lily, Novo Nordisk, & Novartis are all in the GLP-1 drug business which will serve as a good diversification for our CSL and RMD holdings which could face a smaller addressable market if weight loss drugs reduce health issues related to obesity
EBOS Group Ltd. (EBO)
EBOS Group (EBO) operates across Australasia as a multifaceted marketer, wholesaler, and distributor, specializing in healthcare, medical, and pharmaceutical goods. Additionally, the company is involved in marketing and distributing well-known consumer products and brands related to animal care. EBOS’s offerings encompass a variety of sectors such as Healthcare and Animal Care, including services and operations in Logistics and Distribution, Manufacturing, Pharmaceutical and Hospital Wholesaling, Sales and Marketing, Retail Brands and Services, as well as Veterinary and Pet Care products.
EBOS Group Ltd. (EBO) – Total Portfolio Allocation 2.5%
Entry: $33.4 | Target: $39.1 | Stop: $30.75
Betashares Global Healthcare ETF – (DRUG)
The Betashares Global Healthcare ETF – Currency Hedged (DRUG) offers an easy, affordable, and clear way to invest in the world’s largest healthcare companies. This Fund strives to mirror the results of an index (excluding costs and expenses) that tracks the performance of the most significant healthcare firms globally by market capitalization, excluding Australian companies, while adjusting for currency fluctuations into Australian dollars.
Betashares Global Healthcare ETF – (DRUG) – Total Portfolio Allocation 2.5%
Entry: $8.2 | Target: $9.2 | Stop: $7.2
Disclaimer: The recommendation given is general advice only. It does not take into account your personal objectives, financial situation, or specific needs. This information should not be your sole resource when making such decisions. We strongly recommend you to seek the advice of financial, taxation, and legal professionals before finalising any investment decisions.